Literature DB >> 18391499

Roles of FGFR2 and twist in human craniosynostosis: insights from genetic mutations in cranial osteoblasts.

Pierre J Marie1, Karim Kaabeche, Hind Guenou.   

Abstract

Recent advances in molecular genetics have led to a better understanding of the role of specific genes such as fibroblast growth factor receptor (FGFR) and Twist in cranial bone formation. Specifically, the analysis of osteoblast abnormalities induced by FGFR2 and Twist genetic mutations inducing craniosynostosis in humans has provided some insights into the role of these genes in the premature cranial suture formation in syndromic craniosynostosis. This also led to a better understanding of the cellular and molecular mechanisms that control osteoblast biology and pathology in humans. In this review paper, we summarize the effects of FGFR2 and Twist genetic mutations resulting in altered osteoblast phenotype and premature cranial fusion based on our analysis in human syndromic craniosynostosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391499     DOI: 10.1159/000115036

Source DB:  PubMed          Journal:  Front Oral Biol        ISSN: 0301-536X


  17 in total

Review 1.  Cadherin-mediated cell-cell adhesion and signaling in the skeleton.

Authors:  Pierre J Marie; Eric Haÿ; Dominique Modrowski; Leila Revollo; Gabriel Mbalaviele; Roberto Civitelli
Journal:  Calcif Tissue Int       Date:  2013-05-09       Impact factor: 4.333

Review 2.  Craniosynostosis - Recognition, clinical characteristics, and treatment.

Authors:  Nina Kajdic; Peter Spazzapan; Tomaz Velnar
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

3.  TWIST1 silencing enhances in vitro and in vivo osteogenic differentiation of human adipose-derived stem cells by triggering activation of BMP-ERK/FGF signaling and TAZ upregulation.

Authors:  Natalina Quarto; Kshemendra Senarath-Yapa; Andrea Renda; Michael T Longaker
Journal:  Stem Cells       Date:  2015-03       Impact factor: 6.277

4.  Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth.

Authors:  Neus Martínez-Abadías; Christopher Percival; Kristina Aldridge; Cheryl A Hill; Timothy Ryan; Satama Sirivunnabood; Yingli Wang; Ethylin Wang Jabs; Joan T Richtsmeier
Journal:  Dev Dyn       Date:  2010-11       Impact factor: 3.780

5.  Fibroblast growth factor expression during skeletal fracture healing in mice.

Authors:  Gregory J Schmid; Chikashi Kobayashi; Linda J Sandell; David M Ornitz
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

Review 6.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

7.  Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice.

Authors:  Yingli Wang; Miao Sun; Victoria L Uhlhorn; Xueyan Zhou; Inga Peter; Neus Martinez-Abadias; Cheryl A Hill; Christopher J Percival; Joan T Richtsmeier; David L Huso; Ethylin Wang Jabs
Journal:  BMC Dev Biol       Date:  2010-02-22       Impact factor: 1.978

Review 8.  Understanding craniosynostosis as a growth disorder.

Authors:  Kevin Flaherty; Nandini Singh; Joan T Richtsmeier
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-03-22       Impact factor: 5.814

9.  p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.

Authors:  Yingli Wang; Xueyan Zhou; Kurun Oberoi; Robert Phelps; Ross Couwenhoven; Miao Sun; Amélie Rezza; Greg Holmes; Christopher J Percival; Jenna Friedenthal; Pavel Krejci; Joan T Richtsmeier; David L Huso; Michael Rendl; Ethylin Wang Jabs
Journal:  J Clin Invest       Date:  2012-05-15       Impact factor: 14.808

10.  Genetic analysis of vertebral trabecular bone density and cross-sectional area in older men.

Authors:  J M Zmuda; L M Yerges-Armstrong; S P Moffett; L Klei; C M Kammerer; K Roeder; J A Cauley; A Kuipers; K E Ensrud; C S Nestlerode; A R Hoffman; C E Lewis; T F Lang; E Barrett-Connor; R E Ferrell; E S Orwoll
Journal:  Osteoporos Int       Date:  2010-12-09       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.